Teva Bets on Reformulating Old Drugs as Investors Say ‘Show Me’

Teva Bets on Reformulating Old Drugs as Investors Say ‘Show Me’

Adam Reynolds/Bloomberg

A logo is displayed at the entrance to Teva Pharmaceutical Industries Ltd.'s headquarters in Jerusalem, Israel. Teva became the biggest generic-drug maker through an acquisitive strategy that led to more than 20 deals in the past decade.